Skip to main content

and
  1. Article

    Open Access

    A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial

    Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic alter...

    Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi in npj Precision Oncology (2021)